Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Feb 5, 2026

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics
04:01

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics

Published on: March 15, 2024

2.0K

Multiomic Medulloblastomas.

Eric P Rahmann1, Richard J Gilbertson2

  • 1CRUK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK.

Cancer Cell
|September 12, 2018
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Early α-synuclein-mediated mitochondrial dysfunction in a human cell model of Parkinson's disease dementia.

Communications biology·2026
Same author

ZFTA-RELA ependymomas make itaconate to epigenetically drive fusion expression.

Nature·2026
Same author

Childhood brain tumors instruct cranial hematopoiesis and immunotolerance.

Nature genetics·2026
Same author

Investigation of a global mouse methylome atlas reveals subtype-specific copy number alterations in pediatric cancer models.

Nature genetics·2025
Same author

Retraction Note: Human fetal cerebellar cell atlas informs medulloblastoma origin and oncogenesis.

Nature·2025
Same author

Gene context drift identifies drug targets to mitigate cancer treatment resistance.

Cancer cell·2025

Proteomics adds a new layer to understanding medulloblastoma, a childhood brain tumor. This multiomic approach reveals variations that could lead to new therapies for the disease's four subtypes.

Area of Science:

  • Pediatric oncology
  • Molecular biology
  • Cancer research

Background:

  • Medulloblastoma is a significant childhood brain tumor.
  • Epigenomic and transcriptomic studies have identified four clinically relevant subtypes.
  • A comprehensive understanding requires integrating multiple molecular layers.

Purpose of the Study:

  • To integrate proteomic data with existing epigenomic and transcriptomic data for medulloblastoma.
  • To identify posttranscriptional and posttranslational modifications in medulloblastoma subtypes.
  • To uncover potential therapeutic targets based on multiomic analysis.

Main Methods:

  • Multiomic profiling including epigenomics, transcriptomics, and proteomics.
  • Comparative analysis across different medulloblastoma subtypes.

More Related Videos

Isolation, Enrichment, and Maintenance of Medulloblastoma Stem Cells
06:32

Isolation, Enrichment, and Maintenance of Medulloblastoma Stem Cells

Published on: September 1, 2010

16.8K
Intracranial Orthotopic Allografting of Medulloblastoma Cells in Immunocompromised Mice
05:10

Intracranial Orthotopic Allografting of Medulloblastoma Cells in Immunocompromised Mice

Published on: October 3, 2010

12.6K

Related Experiment Videos

Last Updated: Feb 5, 2026

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics
04:01

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics

Published on: March 15, 2024

2.0K
Isolation, Enrichment, and Maintenance of Medulloblastoma Stem Cells
06:32

Isolation, Enrichment, and Maintenance of Medulloblastoma Stem Cells

Published on: September 1, 2010

16.8K
Intracranial Orthotopic Allografting of Medulloblastoma Cells in Immunocompromised Mice
05:10

Intracranial Orthotopic Allografting of Medulloblastoma Cells in Immunocompromised Mice

Published on: October 3, 2010

12.6K
  • Bioinformatic analysis to identify molecular variations.

    • Main Results:

    • Proteomic data complements epigenomic and transcriptomic profiles.
    • Identification of significant posttranscriptional and posttranslational differences between subtypes.
    • Discovery of molecular alterations with potential therapeutic relevance.

    Conclusions:

    • Proteomics provides critical insights into medulloblastoma heterogeneity.
    • Multiomic data integration enhances our understanding of disease mechanisms.
    • Findings suggest new avenues for targeted therapies in childhood brain tumors.